VOKESTRA Trademark
Trademark Overview
On Thursday, October 23, 2014, a trademark application was filed for VOKESTRA with the United States Patent and Trademark Office. The USPTO has given the VOKESTRA trademark a serial number of 79158892. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Tuesday, October 22, 2024. This trademark is owned by Novartis AG. The VOKESTRA trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the endocrine system, the respiratory system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for the prevention and treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, diabetes; antifungal, anti-inf...
General Information
| Serial Number | 79158892 |
| Word Mark | VOKESTRA |
| Filing Date | Thursday, October 23, 2014 |
| Status | 404 - IR CANCELLED - US REGISTRATION CANCELLED |
| Status Date | Tuesday, October 22, 2024 |
| Registration Number | 4750235 |
| Registration Date | Tuesday, June 9, 2015 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, March 24, 2015 |
Trademark Statements
| Goods and Services | Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the endocrine system, the respiratory system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for the prevention and treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, diabetes; antifungal, anti-infective, antiviral preparations and antibiotics |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | F - NOT AVAILABLE |
| Class Status Date | Friday, December 24, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Novartis AG |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | CH |
| Party Name | Novartis AG |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | CH |
| Party Name | Novartis AG |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | CH |
Trademark Events
| Event Date | Event Description |
| Monday, January 26, 2015 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, February 10, 2015 | ASSIGNED TO EXAMINER |
| Wednesday, March 4, 2015 | NOTICE OF PUBLICATION |
| Tuesday, March 24, 2015 | PUBLISHED FOR OPPOSITION |
| Tuesday, June 9, 2015 | REGISTERED-PRINCIPAL REGISTER |
| Thursday, July 9, 2015 | GRANT OF PROTECTION CREATED, TO BE SENT TO IB |
| Tuesday, August 4, 2015 | FINAL DISPOSITION PROCESSED |
| Thursday, January 22, 2015 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Friday, January 23, 2015 | LIMITATION FROM ORIGINAL APPLICATION ENTERED |
| Friday, January 30, 2015 | APPLICATION FILING RECEIPT MAILED |
| Thursday, February 12, 2015 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, August 4, 2015 | FINAL DISPOSITION NOTICE SENT TO IB |
| Wednesday, August 24, 2022 | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED |
| Monday, September 26, 2022 | INVALIDATION PROCESSED |
| Monday, September 26, 2022 | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB |
| Friday, August 21, 2015 | NOTIFICATION PROCESSED BY IB |
| Friday, December 24, 2021 | CANCELLED SECTION 71 |
| Friday, May 16, 2025 | DEATH OF INTERNATIONAL REGISTRATION |
| Tuesday, October 25, 2022 | TOTAL INVALIDATION PROCESSED BY THE IB |
